Pincott Emma Siân, Burch Michael
Department of Cardiology, Great Ormond Street Hospital, Great Ormond Street, London, UK.
Future Cardiol. 2012 Mar;8(2):161-9. doi: 10.2217/fca.12.13.
This article reports on the evolving field of stem cell therapy and its impact on the management of cardiac pathology, in particular congenital heart disease. To date, stem cell therapy has focused on cardiomyoplasty for heart muscle disease, stem cell therapies are already in clinical use for these disorders. Research is now also supporting the potential role of stem cell therapy for congenital heart disease. In the future it may be possible to use stem cells to create cellular grafts and structures that may be surgically implanted into the disordered heart using bioengineering technology. Different types of stem cells have been evaluated and the identification of specific cardiac stem cells offers great potential. Preliminary animal studies investigating fetal cardiac therapies are also underway. These new directions for stem cell research provide exciting potential for the future management of congenital heart disease.
本文报道了干细胞治疗这一不断发展的领域及其对心脏疾病,尤其是先天性心脏病治疗的影响。迄今为止,干细胞治疗主要集中于针对心肌疾病的心肌成形术,干细胞疗法已在临床上用于治疗这些疾病。目前的研究也支持干细胞治疗在先天性心脏病治疗中的潜在作用。未来,利用生物工程技术,有可能使用干细胞制造细胞移植物和结构,然后通过手术植入患病心脏。不同类型的干细胞已得到评估,特定心脏干细胞的识别具有巨大潜力。关于胎儿心脏治疗的初步动物研究也正在进行。干细胞研究的这些新方向为先天性心脏病的未来治疗提供了令人兴奋的潜力。